Long Term Administration of Endothelin Receptor Antagonist Improves Coronary Endothelial Function in Patients with Early Atherosclerosis

BACKGROUND: Endothelin (ET-1) is one of the most potent vasoconstrictors, and plays a seminal role in the pathogenesis of atherosclerosis. The current study was designed to test the hypothesis that long term treatment with an endothelin-A (ET(A)) receptor antagonist improves coronary endothelial fun...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Reriani, Martin, Raichlin, Eugenia, Prasad, Abhiram, Mathew, Verghese, Pumper, Geralyn M., Nelson, Rebecca E., Lennon, Ryan, Rihal, Charanjit, Lerman, Lilach O., Lerman, Amir
Формат: Artigo
Язык:Inglês
Опубликовано: 2010
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2946239/
https://ncbi.nlm.nih.gov/pubmed/20733096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.967406
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы